These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35504814)

  • 1. Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation.
    Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Fujitaka K; Hamada H; Hattori N
    Respir Investig; 2022 Jul; 60(4):531-542. PubMed ID: 35504814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.
    Manichaikul A; Sun L; Borczuk AC; Onengut-Gumuscu S; Farber EA; Mathai SK; Zhang W; Raghu G; Kaufman JD; Hinckley-Stukovsky KD; Kawut SM; Jelic S; Liu W; Fingerlin TE; Schwartz DA; Sell JL; Rich SS; Barr RG; Lederer DJ
    Ann Am Thorac Soc; 2017 May; 14(5):628-635. PubMed ID: 28248552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbation of interstitial lung disease after procedures.
    Amundson WH; Racila E; Allen T; Dincer HE; Tomic R; Bhargava M; Perlman DM; Kim HJ
    Respir Med; 2019 Apr; 150():30-37. PubMed ID: 30961948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: Comparison with idiopathic pulmonary fibrosis.
    Otsuka J; Yoshizawa S; Kudo K; Osoreda H; Ishimatsu A; Taguchi K; Moriwaki A; Wakamatsu K; Iwanaga T; Yoshida M
    Respir Med; 2022; 200():106898. PubMed ID: 35696743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute exacerbations of interstitial lung disease.
    Azadeh N; Moua T; Baqir M; Ryu JH
    Expert Rev Respir Med; 2018 Apr; 12(4):309-313. PubMed ID: 29486130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute exacerbation in antineutrophil cytoplasmic antibody-associated interstitial lung disease: Clinical features and risk factors.
    Otsuka J; Yoshizawa S; Ikematsu Y; Kudo K; Osoreda H; Ishimatsu A; Taguchi K; Moriwaki A; Wakamatsu K; Iwanaga T; Yoshida M
    Respir Med; 2022 Nov; 203():106992. PubMed ID: 36252462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Horimasu Y; Ohshimo S; Fujitaka K; Hamada H; Mazur W; Kohno N; Hattori N
    Respirology; 2017 Jul; 22(5):965-971. PubMed ID: 28198072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases.
    Ba C; Wang H; Jiang C; Shi X; Jin J; Fang Q
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
    Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
    Salonen J; Vähänikkilä H; Purokivi M; Kaarteenaho R
    PLoS One; 2020; 15(11):e0242860. PubMed ID: 33253258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP.
    Kyung SY; Byun KH; Yoon JY; Kim YJ; Lee SP; Park JW; Lee BH; Park JS; Jang AS; Park CS; Jeong SH
    Int J Clin Exp Pathol; 2014; 7(1):221-8. PubMed ID: 24427342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
    Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
    Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease.
    Adams CJ; Chohan K; Rozenberg D; Kavanagh J; Greyling G; Shapera S; Fisher JH
    Lung; 2021 Aug; 199(4):379-387. PubMed ID: 34347146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between acute exacerbation and progressive pulmonary fibrosis in interstitial lung disease: a retrospective cohort study.
    Zhai L; Wang Z; Yu W
    Ther Adv Respir Dis; 2024; 18():17534666241276800. PubMed ID: 39235441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
    Atzeni IM; Al-Adwi Y; Doornbos-van der Meer B; Roozendaal C; Stel A; van Goor H; Gan CT; Dickinson M; Timens W; Smit AJ; Westra J; Mulder DJ
    Front Immunol; 2023; 14():1189257. PubMed ID: 37409127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease.
    Salonen J; Jansa S; Vähänikkilä H; Kaarteenaho R
    BMC Pulm Med; 2023 Jul; 23(1):236. PubMed ID: 37393286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.